Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Rivpra Formulation Logo

Rivpra Formulation

India

Certifications
WHO-Certified
Services
    Sales & Marketing Artwork development & Packaging Services Drug Development

Company Overview

Rivpra formulation is an integrated pharmaceutical company with core competency in the development and manufacture of highly effective and affordable medicines to treat various ailments and diseases.

Established in 2008, Rivpra Formulations is a debt-free, and profit-making ISO-certified pharmaceutical company with a state-of-the-art infrastructure set up in compliance with WHO-cGMP standards.

We are a service provider for contract pharma manufacturing in India. The company deals in formulation development, licensing, and commercial manufacturing of generic, and branded generic including nutraceutical and cosmetic products.


Downloadable Documents
Company Information
Address: Radisson Blu, KM Trade Tower, 11th Floor, Office No. 1006 & 1008, H-3, Kaushambi, Ghaziabad – 201010, Uttar Pradesh, India
Established: 2020
Nature of Business: Manufacturer
Turnover: 50 Million
No. of Employees:
LinkedIn:

Frequently asked questions

Rivpra Formulation operates as a manufacturer based in India. Full product specifications are available on the company profile.

Rivpra Formulation holds the following certifications on its PharmaTradz profile: WHO-Certified. Certificates are verified at onboarding and copies can be requested with your enquiry.

Use the enquiry button on this profile or send an RFP with your product, strength, destination market and quantity. Your requirement reaches the supplier and the PharmaTradz BD team, and a structured quote is returned to you.

Suppliers listed on PharmaTradz export across Asia, Africa, Latin America, MENA, the EU and CIS markets. Share your destination market in your enquiry to confirm registration status, documentation and export capability for your country. Controlled substances are supplied strictly against valid import and export permits.

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.